Cargando…
Inhibition of DEK Enhances Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in T-Cell Acute Lymphoblastic Leukemia Cells
T-cell acute lymphoblastic leukemia (T-ALL) is a serious hematological tumor derived from early T-cell progenitors, which is extremely resistant to chemotherapy. Classically, doxorubicin (DOX) is an effective first-line drug for the treatment of T-ALL; however, DOX resistance limits its clinical eff...
Autores principales: | Tian, Xiaoxue, Zhu, Zeyu, Wang, Guangming, Xu, Jun, Liang, Aibin, Zhang, Wenjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236779/ https://www.ncbi.nlm.nih.gov/pubmed/35769815 http://dx.doi.org/10.1155/2022/9312971 |
Ejemplares similares
-
Sulforaphane Induces Cell Cycle Arrest and Apoptosis in Acute Lymphoblastic Leukemia Cells
por: Suppipat, Koramit, et al.
Publicado: (2012) -
SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression
por: Wang, Fangce, et al.
Publicado: (2021) -
Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2
por: Özçelik, Emrah, et al.
Publicado: (2022) -
Gigantol inhibits cell proliferation and induces apoptosis by regulating DEK in non-small cell lung cancer
por: Cai, Yuxing, et al.
Publicado: (2021) -
Quercetin Effects on Cell Cycle Arrest and Apoptosis and Doxorubicin Activity in T47D Cancer Stem Cells
por: Azizi, Ebrahim, et al.
Publicado: (2022)